title: Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.
abstract: The development of therapeutic vaccines for chronic hepatitis B virus (HBV) infection has been hampered by host immune tolerance and the generally low magnitude and inconsistent immune responses to conventional vaccines and proposed new delivery methods. Electroporation (EP) for plasmid DNA (pDNA) vaccine delivery has demonstrated the enhanced immunogenicity of HBV antigens in various animal models. In the present study, the efficiency of the EP-based delivery of pDNA expressing various reporter genes first was evaluated in normal woodchucks, and then the immunogenicity of an analog woodchuck hepatitis virus (WHV) surface antigen (WHsAg) pDNA vaccine was studied in this model. The expression of reporter genes was greatly increased when the cellular uptake of pDNA was facilitated by EP. The EP of WHsAg-pDNA resulted in enhanced, dose-dependent antibody and T-cell responses to WHsAg compared to those of the conventional hypodermic needle injection of WHsAg-pDNA. Although subunit WHsAg protein vaccine elicited higher antibody titers than the DNA vaccine delivered with EP, T-cell response rates were comparable. However, in WHsAg-stimulated mononuclear cell cultures, the mRNA expression of CD4 and CD8 leukocyte surface markers and Th1 cytokines was more frequent and was skewed following DNA vaccination compared to that of protein immunization. Thus, the EP-based vaccination of normal woodchucks with pDNA-WHsAg induced a skew in the Th1/Th2 balance toward Th1 immune responses, which may be considered more appropriate for approaches involving therapeutic vaccines to treat chronic HBV infection.
authors.affiliation: Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853, USA.
authors.forename: Katherine H
authors.initials: KH
authors.lastname: Liu
authors.forename: Mary A
authors.initials: MA
authors.lastname: Ascenzi
authors.forename: Christine A
authors.initials: CA
authors.lastname: Bellezza
authors.forename: Abraham J
authors.initials: AJ
authors.lastname: Bezuidenhout
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Cote
authors.forename: Gloria
authors.initials: G
authors.lastname: Gonzalez-Aseguinolaza
authors.forename: Drew
authors.initials: D
authors.lastname: Hannaman
authors.forename: Alain
authors.initials: A
authors.lastname: Luxembourg
authors.forename: Claire F
authors.initials: CF
authors.lastname: Evans
authors.forename: Bud C
authors.initials: BC
authors.lastname: Tennant
authors.forename: Stephan
authors.initials: S
authors.lastname: Menne
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D000954:Antigens, Surface / Q000235:genetics / Q000276:immunology*; D018274:Electroporation; D005260:Female; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D017919:Hepatitis B Virus, Woodchuck / Q000235:genetics / Q000276:immunology*; D008392:Marmota; D010957:Plasmids; D013601:T-Lymphocytes / Q000276:immunology; D018417:Th1 Cells / Q000276:immunology; D014611:Vaccination / Q000379:methods*; D019444:Vaccines, DNA / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D014764:Viral Proteins / Q000235:genetics / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D000954:Antigens, Surface; D017325:Hepatitis B Vaccines; D019444:Vaccines, DNA; D014764:Viral Proteins